With a market cap of has a large market cap size. AbbVie Inc. (NYSE: ABBV) has been on the stock market since its IPO date on the 1/2/2013. AbbVie Inc. is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AbbVie Inc., is 8842.88, and so far today it has a volume of 6211. Performance year to date since the 1/2/2013 is 12.80%.
To help you determine whether AbbVie Inc. is undervalued the following values will help you decide. P/E is 19.62 and forward P/E is 11.67. PEG perhaps more useful shows that AbbVie Inc. has a value for PEG of 1.2. P/S ratio is 4.4 and the P/B ratio is 22.82. The P/Cash and P/Free cash flow is 12.18 and 25.31 respectively.
At the current price AbbVie Inc. is trading at, 64.9 (-0.92% today), AbbVie Inc. has a dividend yield of 3.48%, and this is covered by a payout ratio of 64.30%. Earnings per share (EPS) is 3.34, and this is looking to grow in the next year to 17.87% after growing 185.20% this past year. EPS growth quarter over quarter is 31.10%, and 18.20% for sales growth quarter over quarter.
The number of shares outstanding is 1598.96, and the number of shares float is 1598.96. The senior management bring insider ownership to 0.10%, and institutional ownership is at 71.00%. The float short is 4.89%, with the short ratio at a value of 8.84. Management has seen a return on assets of 10.20%, and also a return on investment of 16.90%.
The ability for AbbVie Inc., to deal with debt, means it current ratio is 1.6, and quick ratio is 1.4. Long term debt/equity is 6.35 and total debt/equity is 6.87. In terms of margins, AbbVie Inc. has a gross margin of 79.80%, with its operating margin at 34.20%, and AbbVie Inc. has a profit margin of 23.00%.
The 52 week high is -6.67%, with 45.68% being its 52 week low. The 20 day simple moving average is 5.08% and the 200 day simple moving average is 12.65%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.